Literature DB >> 27335158

A Crisis in the Treatment of Osteoporosis.

Sundeep Khosla1, Elizabeth Shane2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27335158     DOI: 10.1002/jbmr.2888

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  84 in total

1.  Trends and Determinants of Osteoporosis Treatment and Screening in Patients With Rheumatoid Arthritis Compared to Osteoarthritis.

Authors:  Gulsen Ozen; Diane L Kamen; Ted R Mikuls; Bryant R England; Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-03-11       Impact factor: 4.794

2.  Pain and fracture-related limitations persist 6 months after a fragility fracture.

Authors:  Joanna E M Sale; Lucy Frankel; Stephen Thielke; Larry Funnell
Journal:  Rheumatol Int       Date:  2017-06-20       Impact factor: 2.631

3.  Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study.

Authors:  Elizabeth J Samelson; Kerry E Broe; Hanfei Xu; Laiji Yang; Steven Boyd; Emmanuel Biver; Pawel Szulc; Jonathan Adachi; Shreyasee Amin; Elizabeth Atkinson; Claudie Berger; Lauren Burt; Roland Chapurlat; Thierry Chevalley; Serge Ferrari; David Goltzman; David A Hanley; Marian T Hannan; Sundeep Khosla; Ching-Ti Liu; Mattias Lorentzon; Dan Mellstrom; Blandine Merle; Maria Nethander; René Rizzoli; Elisabeth Sornay-Rendu; Bert Van Rietbergen; Daniel Sundh; Andy Kin On Wong; Claes Ohlsson; Serkalem Demissie; Douglas P Kiel; Mary L Bouxsein
Journal:  Lancet Diabetes Endocrinol       Date:  2018-11-28       Impact factor: 32.069

4.  The American Orthopaedic Association's Own the Bone® database: a national quality improvement project for the treatment of bone health in fragility fracture patients.

Authors:  B C Carlson; W A Robinson; N R Wanderman; A N Nassr; P M Huddleston; M J Yaszemski; B L Currier; K J Jeray; K L Kirk; A D Bunta; S Murphy; B Patel; C M Watkins; D L Sietsema; B J Edwards; L L Tosi; P A Anderson; B A Freedman
Journal:  Osteoporos Int       Date:  2018-06-01       Impact factor: 4.507

5.  Dysmobility Syndrome Independently Increases Fracture Risk in the Osteoporotic Fractures in Men (MrOS) Prospective Cohort Study.

Authors:  Bjoern Buehring; Karen E Hansen; Brian L Lewis; Steven R Cummings; Nancy E Lane; Neil Binkley; Kristine E Ensrud; Peggy M Cawthon
Journal:  J Bone Miner Res       Date:  2018-06-21       Impact factor: 6.741

6.  Changing Patterns in Oral Bisphosphonate Initiation in Women between 2004 and 2012.

Authors:  David R Lee; Bruce Ettinger; Malini Chandra; Rita L Hui; Joan C Lo
Journal:  J Am Geriatr Soc       Date:  2017-02-02       Impact factor: 5.562

7.  Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.

Authors:  Ranya Elsayed; Pheba Abraham; Mohamed E Awad; Zoya Kurago; Balasudha Baladhandayutham; Gary M Whitford; David H Pashley; Charles E McKenna; Mohammed E Elsalanty
Journal:  Bone       Date:  2018-02-09       Impact factor: 4.398

Review 8.  Osteoporosis treatment: recent developments and ongoing challenges.

Authors:  Sundeep Khosla; Lorenz C Hofbauer
Journal:  Lancet Diabetes Endocrinol       Date:  2017-07-07       Impact factor: 32.069

9.  Bone: Romosozumab - getting there but not quite yet.

Authors:  Socrates E Papapoulos
Journal:  Nat Rev Endocrinol       Date:  2016-11-04       Impact factor: 43.330

10.  β-Blockers and bone health.

Authors:  Lorenz C Hofbauer; Holger Henneicke
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.